These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15498005)

  • 1. Large cyclic peptides as cores of multivalent ligands: application to inhibitors of receptor binding by cholera toxin.
    Zhang Z; Liu J; Verlinde CL; Hol WG; Fan E
    J Org Chem; 2004 Oct; 69(22):7737-40. PubMed ID: 15498005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspanning bivalent ligands as improved surface receptor binding inhibitors of the cholera toxin B pentamer.
    Pickens JC; Mitchell DD; Liu J; Tan X; Zhang Z; Verlinde CL; Hol WG; Fan E
    Chem Biol; 2004 Sep; 11(9):1205-15. PubMed ID: 15380181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin.
    Zhang Z; Merritt EA; Ahn M; Roach C; Hou Z; Verlinde CL; Hol WG; Fan E
    J Am Chem Soc; 2002 Nov; 124(44):12991-8. PubMed ID: 12405825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Prediction of Multivalent Ligand-Receptor Binding Affinities for Influenza, Cholera, and Anthrax Inhibition.
    Liese S; Netz RR
    ACS Nano; 2018 May; 12(5):4140-4147. PubMed ID: 29474056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution- and solid-phase syntheses of guanidine-bridged, water-soluble linkers for multivalent ligand design.
    Zhang Z; Pickens JC; Hol WG; Fan E
    Org Lett; 2004 Apr; 6(9):1377-80. PubMed ID: 15101746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
    Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
    J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF receptor-binding cyclic peptides designed with artificial amino-acid linkers.
    Shibata K; Maruyama-Takahashi K; Yamasaki M; Hirayama N
    Biochem Biophys Res Commun; 2006 Mar; 341(2):483-8. PubMed ID: 16427611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cholera toxin binding properties of multivalent GM1 mimics.
    Arosio D; Vrasidas I; Valentini P; Liskamp RM; Pieters RJ; Bernardi A
    Org Biomol Chem; 2004 Jul; 2(14):2113-24. PubMed ID: 15254640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivalent drug design and inhibition of cholera toxin by specific and transient protein-ligand interactions.
    Liu J; Begley D; Mitchell DD; Verlinde CLMJ; Varani G; Fan E
    Chem Biol Drug Des; 2008 May; 71(5):408-419. PubMed ID: 18373548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,5-Substituted phenyl galactosides as leads in designing effective cholera toxin antagonists; synthesis and crystallographic studies.
    Mitchell DD; Pickens JC; Korotkov K; Fan E; Hol WG
    Bioorg Med Chem; 2004 Mar; 12(5):907-20. PubMed ID: 14980603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 1.25 A resolution refinement of the cholera toxin B-pentamer: evidence of peptide backbone strain at the receptor-binding site.
    Merritt EA; Kuhn P; Sarfaty S; Erbe JL; Holmes RK; Hol WG
    J Mol Biol; 1998 Oct; 282(5):1043-59. PubMed ID: 9753553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
    Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
    J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution versus solid-phase cyclization strategies for large sidechain lactam-bridged peptides: a comparative study.
    Camarero JA; Cairó JJ; Giralt E; Andreu D
    J Pept Sci; 1995; 1(4):241-50. PubMed ID: 9223002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting.
    Manzoni L; Belvisi L; Arosio D; Civera M; Pilkington-Miksa M; Potenza D; Caprini A; Araldi EM; Monferini E; Mancino M; Podestà F; Scolastico C
    ChemMedChem; 2009 Apr; 4(4):615-32. PubMed ID: 19212960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding potential between the cholera toxin B-oligomer and its receptor.
    Cai XE; Yang J
    Biochemistry; 2003 Apr; 42(14):4028-34. PubMed ID: 12680755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to platelets.
    Kouki A; Mitsios JV; Sakarellos-Daitsiotis M; Sakarellos C; Tselepis AD; Tsikaris V; Tsoukatos DC
    J Thromb Haemost; 2005 Oct; 3(10):2324-30. PubMed ID: 16129021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
    Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
    Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholera and Shiga toxin B-subunits: thermodynamic and structural considerations for function and biomedical applications.
    Pina DG; Johannes L
    Toxicon; 2005 Mar; 45(4):389-93. PubMed ID: 15733559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of cyclic and branched peptide analogues as ligands for cholecystokinin type 1 receptor.
    De Luca S; De Capua A; Saviano M; Della Moglie R; Aloj L; Tarallo L; Pedone C; Morelli G
    Bioorg Med Chem; 2007 Sep; 15(17):5845-53. PubMed ID: 17562367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity.
    Kato-Takagaki K; Suzuki N; Yokoyama F; Takaki S; Umezawa K; Higo J; Mochizuki M; Kikkawa Y; Oishi S; Utani A; Nomizu M
    Biochemistry; 2007 Feb; 46(7):1952-60. PubMed ID: 17261031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.